NovoCure Limited NVCR
Set alert
13.43 USD +0.22 +1.67%
As of Nov 3, 1:42 PM ET
13.21 Day range 13.56
9.82 52-week range 21.45
- YTD
- +3.87%
- 1 year
- +9.81%
- Open
- 13.30
- Prev close
- 13.21
- Mkt cap
- 1.57B
- Vol
- 460.89K
- Avg vol
- 1.44M
- EPS
- -1.06
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.21
- High
- 13.56
- Forward P/E
- -17.87
- Beta
- 1.08
- Short ratio
- 9.27
- Inst. own
- 90.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 25, 2027
- 50-d avg
- 15.79
- 200-d avg
- 14.82
- 1y target
- 26.43
MAX chart
Events in this range
- May 4, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Oct 30, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Oct 30, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (32)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Feb 1, 2025 | 1 year ago |
| SMA: Bullish | Nov 1, 2024 | 2 years ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 1, 2024 | 2 years ago |
| SMA: Bullish | May 1, 2024 | 2 years ago |
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| SMA: Bullish | Jan 1, 2023 | 3 years ago |
| SMA: Bearish | Dec 1, 2022 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Oct 1, 2021 | 5 years ago |
| MACD: Sell Signal | Sep 1, 2021 | 5 years ago |
| SMA: Bearish | Jul 1, 2021 | 5 years ago |
Newest 20 of 32.
Financial health
Altman Z-Score
0.57 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -10.6×
FY 2016 5y median -19.1× FY 2025
P/S 2.2×
FY 2016 5y median 5.3× FY 2025
P/B 4.2×
FY 2016 5y median 8.9× FY 2025
P/FCF -19.0×
FY 2016 5y median -15.8× FY 2025
EV/EBITDA -13.4×
FY 2016 5y median -34.1× FY 2025
EV/Sales 2.5×
FY 2016 5y median 6.2× FY 2025
FCF Yield -5.3%
FY 2016 5y median -2.2% FY 2025
Profitability
Gross Margin 74.5%
FY 2016 5y median 77.3% FY 2025
Operating Margin -23.5%
FY 2016 5y median -23.5% FY 2025
Net Margin -20.8%
FY 2016 5y median -20.8% FY 2025
ROE -40.0%
FY 2016 5y median -40.0% FY 2025
ROIC -25.9%
FY 2016 5y median -16.2% FY 2025
ROA -16.9%
FY 2016 5y median -13.6% FY 2025
Growth (YoY)
Revenue 8.3%
FY 2016 FY 2025
Operating Income 9.8%
FY 2016 FY 2025
EPS (diluted) 21.8%
FY 2016 FY 2025
Free Cash Flow -9.3%
FY 2016 FY 2025
Financial Health
Current Ratio 2.9×
FY 2016 5y median 5.8× FY 2025
Quick Ratio 2.7×
FY 2016 5y median 5.6× FY 2025
Debt / Equity 0.9×
FY 2016 5y median 1.4× FY 2025
Net Debt / EBITDA -1.5×
FY 2016 5y median -4.7× FY 2025
Interest Coverage 0.0×
FY 2016 5y median -11.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
